Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|August 30, 2022
Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitisMarcus Maurer, Dorothy S Cheung, Wiebke Theess, et al.
Dermatology and Therapy|April 25, 2026
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 TrialAmy S Paller, Michael J Cork, H Chih-Ho Hong, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 10, 2021
Differing perceptions of asthma control and treatment effectiveness by patients with severe asthma and treating subspecialists in the United StatesReynold A Panettieri, Bradley E Chipps, Wendy C Moore, et al.
Allergy and Asthma Proceedings|October 29, 2025
Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticariaDiane Whalley, Maria-Magdalena Balp, Christel Naujoks, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2024
The Impact of Prior Authorization on Clinical Practice and Patient Care Outcomes: A Work Group Report of the AAAAI Prior Authorization Task ForceJonathan A Bernstein, Deepthi Gadde, Mohamed Yassin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2025
The Art of Clinical NegotiationAlexandra Conway, Navya Kartha, Aikaterini Anagnostou, et al.
Dermatology and Therapy|March 17, 2025
Cluster Analysis of Clinical Remission and Relapse Patterns in Chronic Urticaria: Results from the PREDICT-CU StudyMaria-Magdalena Balp, Irina Pivneva, Andrii Danyliv, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 21, 2022
Biologic use and outcomes among adults with severe asthma treated by US subspecialistsReynold A Panettieri, Dennis K Ledford, Bradley E Chipps, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2025
Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study resultsDiamant Thaçi, Vivian Laquer, Charles Lynde, et al.
Pragmatic and Observational Research|August 9, 2020
The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial ResultsChristopher S Ambrose, Bradley E Chipps, Wendy C Moore, et al.
Pageof 6